Home › Funds › Kalehua Capital Management LLC › RNA
Kalehua Capital Management LLC position in RNA
ATRIUM THERAPEUTICS INC · Health Care
Kalehua Capital Management LLC reported holding 112,652 shares of RNA (ATRIUM THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$933K, representing 0.70% of its reported portfolio and ranking #19 among its reported holdings. Kalehua Capital Management LLC first reported this position in Q3 2026.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Kalehua Capital Management LLC's RNA position evolved
Kalehua Capital Management LLC first disclosed a stake in RNA in Q3 2026 at 112,652 shares (US$933K).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2026 | 112.65K | $932.76K | New |
About RNA and 13F data
RNA (ATRIUM THERAPEUTICS INC) is a Health Care company. 98 other funds we track also report a position in RNA — the largest reported positions include Sessa Capital IM, L.P. (US$20.2M), TIG Advisors, LLC (US$7.6M), Slotnik Capital, LLC (US$3.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding RNA
- Sessa Capital IM, L.P. 1.50M sh · $20.18M · Q2 2026
- TIG Advisors, LLC 561.53K sh · $7.55M · Q2 2026
- Slotnik Capital, LLC 237.64K sh · $3.20M · Q2 2026
- Arbiter Partners Capital Management LLC 311.72K sh · $2.58M · Q3 2026
- NEXPOINT ASSET MANAGEMENT, L.P. 150.03K sh · $2.02M · Q2 2026
- Bracebridge Capital, LLC 139.24K sh · $1.87M · Q2 2026
- Marble Bar Asset Management LLP 103.85K sh · $1.40M · Q2 2026
- Athos Capital Ltd 107.97K sh · $894.00K · Q3 2026
- Trium Capital LLP 58.38K sh · $483.40K · Q3 2026
- ALETHEA CAPITAL MANAGEMENT, LLC 43.76K sh · $362.32K · Q3 2026
- Twin Securities, Inc. 26.52K sh · $356.65K · Q2 2026
More on Kalehua Capital Management LLC
FAQ
How long has Kalehua Capital Management LLC held RNA?
Kalehua Capital Management LLC has disclosed RNA holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is Kalehua Capital Management LLC's current position in RNA?
As of Q3 2026, Kalehua Capital Management LLC holds 112.65K shares of RNA (ATRIUM THERAPEUTICS INC), valued at $932.76K, representing 0.70% of its reported portfolio and ranking #19.
Has Kalehua Capital Management LLC been buying or selling RNA?
In the latest 13F filing (Q3 2026), Kalehua Capital Management LLC newly opened its position in RNA.
Which other funds hold RNA?
Other major institutional holders of RNA include Sessa Capital IM, L.P., TIG Advisors, LLC, Slotnik Capital, LLC, among 98 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.